Learn More
Cayman Chemical RoflumIlast N-oxIde 25mg

Supplier: Cayman Chemical 3397525 MG
A PDE4 inhibitor (IC50 = 2 nM) and active metabolite of roflumilast; selective for PDE4 over PDE1-3 and PDE5 (IC50s = >10,000 nM for all); It reduces TNF-α-induced ICAM-1 and eotaxin levels when used in combination with PGE2 in GM06114 human fetal lung fibroblasts (IC50s = 0.9 and 0.5 nM, respectively); reverses cigarette smoke extract-induced reductions in ciliary beat frequency in isolated human bronchial epithelial cells at 2 nM; also increases plasma GLP-1 levels in a glucose challenge in diabetic db/db mice at 10 mg/kg, as well as prevents increases in blood glucose in db/db mice at 3 mg/kg per day
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.